Joseph M. Tibaldi

4.2k total citations
26 papers, 524 citations indexed

About

Joseph M. Tibaldi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Joseph M. Tibaldi has authored 26 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Joseph M. Tibaldi's work include Diabetes Treatment and Management (18 papers), Diabetes Management and Research (16 papers) and Pancreatic function and diabetes (11 papers). Joseph M. Tibaldi is often cited by papers focused on Diabetes Treatment and Management (18 papers), Diabetes Management and Research (16 papers) and Pancreatic function and diabetes (11 papers). Joseph M. Tibaldi collaborates with scholars based in United States, United Kingdom and Australia. Joseph M. Tibaldi's co-authors include Martin I. Surks, Uriel S. Barzel, Robert E. Rakel, Daniel L. Lorber, Helena W. Rodbard, Michael Lyng Wolden, S Gough, AG Unnikrishnan, Andreas Liebl and Andrew J. Krentz and has published in prestigious journals such as Journal of Clinical Investigation, Endocrine Reviews and Diabetes.

In The Last Decade

Joseph M. Tibaldi

25 papers receiving 491 citations

Peers

Joseph M. Tibaldi

EDM

SURGE

GENET

PHYSI

Vaneeta Bamba United States

Anna Paola Frongia Italy

Ragnhildur Bergthorsdottir Sweden

Hye-Sook Min South Korea

Fatma Mnif Tunisia

Maria Dracopoulou Greece

María Molina‐Vega Spain

Zixin Cai China

Giuseppe Argiolas Italy

David B. Jacobs United States

Vaneeta Bamba United States

Joseph M. Tibaldi

202 ×0.5

EDM

136 ×1.1

SURGE

123 ×1.2

129 ×1.6

GENET

76 ×1.5

PHYSI

Citations per year, relative to Joseph M. Tibaldi Joseph M. Tibaldi (= 1×) peers Vaneeta Bamba

Countries citing papers authored by Joseph M. Tibaldi

Since Specialization

Citations

This map shows the geographic impact of Joseph M. Tibaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph M. Tibaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph M. Tibaldi more than expected).

Fields of papers citing papers by Joseph M. Tibaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph M. Tibaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph M. Tibaldi. The network helps show where Joseph M. Tibaldi may publish in the future.

Co-authorship network of co-authors of Joseph M. Tibaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph M. Tibaldi. A scholar is included among the top collaborators of Joseph M. Tibaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph M. Tibaldi. Joseph M. Tibaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tibaldi, Joseph M., et al.. (2020). How Effective Is the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) in Different Patient Populations, and When Should It Be Used in Clinical Practice?. Clinical Diabetes. 38(4). 339–347. 7 indexed citations

Tibaldi, Joseph M., et al.. (2018). A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes. Diabetes Obesity and Metabolism. 21(4). 1001–1009. 31 indexed citations

Tibaldi, Joseph M.. (2014). Evolution of Insulin: From Human to Analog. The American Journal of Medicine. 127(10). S25–S38. 51 indexed citations

Tibaldi, Joseph M.. (2014). Incorporating Incretin-Based Therapies into Clinical Practice for Patients with Type 2 Diabetes. Advances in Therapy. 31(3). 289–317. 10 indexed citations

Tibaldi, Joseph M.. (2014). Achieving Glycemic Goals With Addition of Incretin-based Therapies to Insulin in Patients With Type 2 Diabetes Mellitus. The American Journal of the Medical Sciences. 347(6). 491–501. 5 indexed citations

Tibaldi, Joseph M.. (2012). Evolution of Insulin Development: Focus on Key Parameters. Advances in Therapy. 29(7). 590–619. 43 indexed citations

Tibaldi, Joseph M.. (2011). Intensifying Insulin Therapy in Type 2 Diabetes Mellitus: Dosing Options for Insulin Analogue Premixes. Clinical Therapeutics. 33(11). 1630–1642. 5 indexed citations

Unnikrishnan, AG, Joseph M. Tibaldi, Andrew J. Krentz, et al.. (2009). Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement. International Journal of Clinical Practice. 63(11). 1571–1577. 29 indexed citations

Tibaldi, Joseph M.. (2009). Importance of Postprandial Glucose Levels as a Target for Glycemic Control in Type 2 Diabetes. Southern Medical Journal. 102(1). 60–66. 28 indexed citations

10.

Tibaldi, Joseph M.. (2008). Intensifying Treatment in Poorly Controlled Type 2 Diabetes Mellitus: Case Reports. The American Journal of Medicine. 121(6). S30–S34. 1 indexed citations

11.

Tibaldi, Joseph M.. (2008). Initiating and Intensifying Insulin Therapy in Type 2 Diabetes Mellitus. The American Journal of Medicine. 121(6). S20–S29. 25 indexed citations

12.

Tibaldi, Joseph M.. (2008). Preserving insulin secretion in Type 2 diabetes mellitus. Expert Review of Endocrinology & Metabolism. 3(2). 147–159. 6 indexed citations

13.

Tibaldi, Joseph M.. (2007). Actions of insulin beyond glycemic control: A perspective on insulin detemir. Advances in Therapy. 24(4). 868–882. 16 indexed citations

14.

Gough, S & Joseph M. Tibaldi. (2007). Biphasic Insulin Aspart in Type??2??Diabetes Mellitus. Clinical Drug Investigation. 27(5). 299–324. 12 indexed citations

15.

Tibaldi, Joseph M. & Robert E. Rakel. (2007). Why, when and how to initiate insulin therapy in patients with type 2 diabetes. International Journal of Clinical Practice. 61(4). 633–644. 18 indexed citations

16.

Tibaldi, Joseph M., et al.. (1992). Postprandial hypoglycemia in islet beta cell hyperplasia with adenomatosis of the pancreas. Journal of Surgical Oncology. 50(1). 53–57. 6 indexed citations

17.

Tibaldi, Joseph M., et al.. (1990). Diabetic ketoacidosis and insulin resistance with subcutaneous terbutaline infusion: A case report. American Journal of Obstetrics and Gynecology. 163(2). 509–510. 22 indexed citations

18.

Tibaldi, Joseph M., et al.. (1986). Thyrotoxicosis in the very old. The American Journal of Medicine. 81(4). 619–622. 57 indexed citations

19.

Tibaldi, Joseph M. & Uriel S. Barzel. (1985). Thyroxine supplementation. Method for the prevention of clinical hypothyroidism. The American Journal of Medicine. 79(2). 241–244. 15 indexed citations

20.

Tibaldi, Joseph M. & Martin I. Surks. (1985). Animal Models of Nonthyroidal Disease*. Endocrine Reviews. 6(1). 87–102. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact